People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Humanigen, Inc | — | Pharmaceuticals | Series B | $39.2M | $16.8M | 2016 |
Dean Witter III at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dean Witter III on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Harrison | 1 | 8 |
| James Healy | 1 | 8 |
| DENNIS HENNER | 1 | 5 |
| Brigitte Smith | 1 | 5 |
| Cameron Durrant | 1 | 5 |
| David Moradi | 1 | 2 |
| Ezra Friedberg | 1 | 2 |
| Gary Lyons | 1 | 2 |
| Ted Love | 1 | 2 |
| David Pritchard | 1 | 2 |
| Robert Savage | 1 | 2 |
| Ray Withy | 1 | 1 |
| Jeanne Jew | 1 | 1 |
| Rainer Boehm | 1 | 1 |
| Denise Gilbert | 1 | 1 |
| Dale Chappell | 1 | 1 |
| Timothy Morris | 1 | 1 |
| Greg Jester | 1 | 1 |
| Ronald Barliant | 1 | 1 |
| Morgan Lam | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.